Huimin Wang - Edwards Lifesciences Insider

EW -- USA Stock  

USD 138.06  0.77  0.56%

  President
Dr. Huimin Wang M.D., is Corporationrationrate Vice President, Japan, Asia Pacific of Edwards Lifesciences Corporationrationration. since 2010. From 2004 to 2010, he served as Corporationrationrate Vice President, Japan and Intercontinental Regions and was Corporationrationrate Vice President, Japan from 2000 to 2004. Previously, he served in a number of roles with Baxter Healthcare Corporationrationration, including Senior Manager of Strategy Development, Director of ProductTherapy for the Renal Division in Japan, President of Medical Systems and Devices in Japan, and was a representative director of Baxter Limited, a Japan corporation, through September 2002. Before joining Baxter, Dr. Wang was a senior associate with Booz, Allen Hamilton in Chicago, Vice President of Integrated Strategies, a consulting and venture management firm he cofounded, and an associate with McKinsey Company. Dr. Wang is a Visiting Associate Professor of anesthesiology at Keio University.
Age: 60  President Since 2010      
949-250-2500  http://www.edwards.com
Wang earned his Doctor of Medicine degree from Kagoshima University in Japan and was a Resident and Staff Physician in anesthesiology at Keio University Hospital in Tokyo. He earned his MBA from the University of Chicago.

Huimin Wang Latest Insider Activity

Management Efficiency

The company has Return on Asset (ROA) of 11.47 % which means that for every $100 of asset it generated profit of $11.47. This is typical in the industry. Likewise, it shows return on total equity (ROE) of 21.51 % which means that it produced $21.51 on every 100 dollars invested by current stockholders.
The company reports 1.19 B of total liabilities with total debt to equity ratio (D/E) of 37.7 which implies that the company may not be able to produce enough cash to satisfy its debt commitments. Edwards Lifesciences Corporation has Current Ratio of 2.23 indicating that it is in good position to pay out its debt commitments in time.

Similar Executives

Showing few of many executives

PRESIDENT Since

Heather MasonAbbott Laboratories
2015
Frank VandeputteSecond Sight Medical Products
2017
Martin ShirleyDigirad Corporation
2016
Deepak NathAbbott Laboratories
2015
Jaime ContrerasAbbott Laboratories
2013
Scott WhiteAbbott Laboratories
2013
Thomas GephartDynatronics Corporation
2016
JeanYves PaveeAbbott Laboratories
2015
Brad GreathouseEncision
2014
Brian BakerDynatronics Corporation
2018
Roger BirdAbbott Laboratories
2015
Charles FoltzAbbott Laboratories
2013
Douglas SampsonDynatronics Corporation
2009
Murthy SimhambhatlaAbbott Laboratories
2013
Jared WatkinAbbott Laboratories
2015
Thomas FrinziAbbott Laboratories
2016
Eric FainAbbott Laboratories
2017
Georges VosAbbott Laboratories
2013
Anthony MosesSecond Sight Medical Products
2015
Robert FordAbbott Laboratories
2015
Daniel SalvadoriAbbott Laboratories
2014

Entity Summary

Edwards Lifesciences Corporation provides products and technologies to treat structural heart disease and critically ill patients in the United States and internationally. Edwards Lifesciences Corporation was founded in 1999 and is headquartered in Irvine, California. Edwards Lifesciences operates under Medical Devices classification in USA and traded on BATS Exchange. It employs 12200 people.Edwards Lifesciences Corporation (EW) is traded on BATS Exchange in USA. It is located in CALIFORNIA U.S.A and employs 12,200 people. Edwards Lifesciences is listed under Medical Equipment category by Fama And French industry classification.

Edwards Lifesciences Leadership Team

John Cardis, Independent Director
Wesley Schack, Presiding Independent Director
Larry Wood, Corporate VP of Transcatheter Heart Valve
Nicholas Valeriani, Director
Leslie Heisz, Director
Catherine Szyman, Corporate Vice President Critical Care
Martha Marsh, Director
Huimin Wang, Corporate Vice President Japan, Asia Pacific
JeanLuc Lemercier, Corporate Vice President EMEA (Europe, Middle East and Africa)
Barbara McNeil, Independent Director
Steven Loranger, Director
William Link, Independent Director
Scott Ullem, CFO and Corporate VP
Patrick Verguet, Corporate VP of EMEA, Canada and Latin America
Kieran Gallahue, Director
Bernard Zovighian, Corporate Vice President -Surgical Heart Valve Therapy
David Erickson, Vice President - Investor Relations
Donald Bobo, Corporate VP of Strategy and Corporate Devel.
Michael Mussallem, Chairman and CEO

Stock Performance Indicators

Did you try this?

Run Volatility Analysis Now
   

Volatility Analysis

Get historical volatility and risk analysis based on latest market data
All  Next Launch Volatility Analysis

Pair Correlation

Equities Pair Trading Analysis
Correlation analysis and pair trading evaluation for Edwards Lifesciences and Digirad. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Additionally see Investing Opportunities. Please also try Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.